These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6121052)

  • 21. Psychotherapeutic agents in renal failure.
    Viederman M; Rusk GH
    Am J Med; 1977 Apr; 62(4):529-32. PubMed ID: 15453
    [No Abstract]   [Full Text] [Related]  

  • 22. Psychotropic drug prescription pattern in a developing country (Nigeria). The need for an essential psychotherapeutic drug list.
    Odejide AO; Ban TA
    Int Pharmacopsychiatry; 1982; 17(3):163-9. PubMed ID: 6128330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroscience-based nomenclature (NbN).
    Worley L
    Lancet Psychiatry; 2017 Apr; 4(4):272-273. PubMed ID: 28347426
    [No Abstract]   [Full Text] [Related]  

  • 24. Naming for Psychotropic Drugs: Dilemma and Challenge.
    Uchida H; Fleischhacker W; Juckel G; Gründer G; Bauer M
    Pharmacopsychiatry; 2017 Jan; 50(1):1-2. PubMed ID: 28118674
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuroscience-based nomenclature (jNbN) to replace traditional terminology of psychotropic medications.
    Möller HJ; Schmitt A; Falkai P
    Eur Arch Psychiatry Clin Neurosci; 2016 Aug; 266(5):385-6. PubMed ID: 27216433
    [No Abstract]   [Full Text] [Related]  

  • 26. Classification of psychotropic drugs based on pharmaco-electrocorticographic studies in vigilance-controlled rats.
    Krijzer F; Koopman P; Olivier B
    Neuropsychobiology; 1993; 28(3):122-37. PubMed ID: 7904054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroscience-based Nomenclature: What is it, why is it needed, and what comes next?
    Uchida H
    Psychiatry Clin Neurosci; 2018 Feb; 72(2):50-51. PubMed ID: 29436090
    [No Abstract]   [Full Text] [Related]  

  • 28. A new nomenclature for classifying psychotropic drugs.
    Caraci F; Enna SJ; Zohar J; Racagni G; Zalsman G; van den Brink W; Kasper S; Koob GF; Pariante CM; Piazza PV; Yamada K; Spedding M; Drago F
    Br J Clin Pharmacol; 2017 Aug; 83(8):1614-1616. PubMed ID: 28401576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Teratogenicity of psychotherapeutic medications.
    Elia J; Katz IR; Simpson GM
    Psychopharmacol Bull; 1987; 23(4):531-86. PubMed ID: 2893424
    [No Abstract]   [Full Text] [Related]  

  • 30. The early history of psychotherapeutic drugs.
    Jacobsen E
    Psychopharmacology (Berl); 1986; 89(2):138-44. PubMed ID: 2873606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical use of psychotherapeutic drugs in the elderly.
    de Groot MH
    Drugs; 1974; 8(2):132-8. PubMed ID: 4154836
    [No Abstract]   [Full Text] [Related]  

  • 32. What's in a name? The evolution of the nomenclature of antipsychotic drugs.
    King C; Voruganti LN
    J Psychiatry Neurosci; 2002 May; 27(3):168-75. PubMed ID: 12066446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral effects of psychotherapeutic agents in rats chronically dosed with alpha-acetylmethadol.
    Maickel RP; Lambert CS; Braude MC; Zabik JE
    Commun Psychopharmacol; 1978; 2(1):45-50. PubMed ID: 26496
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of psychotropic agents in dentistry].
    Ceriani C
    Quintessencia; 1981 Apr; 8(4):45-53. PubMed ID: 6120532
    [No Abstract]   [Full Text] [Related]  

  • 35. 'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate.
    Corazza O; Demetrovics Z; van den Brink W; Schifano F
    Int J Drug Policy; 2013 Jan; 24(1):82-3. PubMed ID: 22883544
    [No Abstract]   [Full Text] [Related]  

  • 36. [Towards an automatic classification of psychotropic drugs, based on computerized card-index of their properties].
    Poirier MF; Garreau M; Deniker P
    Ann Med Psychol (Paris); 1982 Jan; 140(1):1-26. PubMed ID: 7114662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature.
    Zohar J; Stahl S; Moller HJ; Blier P; Kupfer D; Yamawaki S; Uchida H; Spedding M; Goodwin GM; Nutt D
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2318-25. PubMed ID: 26527055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotropic drugs and renal failure: translating the evidence for clinical practice.
    Baghdady NT; Banik S; Swartz SA; McIntyre RS
    Adv Ther; 2009 Apr; 26(4):404-24. PubMed ID: 19444657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prescription and monitoring of psychotropic agents].
    Haffen E; Sechter D
    Rev Prat; 2004 May; 54(10):1119-27. PubMed ID: 15369156
    [No Abstract]   [Full Text] [Related]  

  • 40. Adverse cutaneous reactions to psychotropic drugs.
    Srebrnik A; Hes JP; Brenner S
    Acta Derm Venereol Suppl (Stockh); 1991; 158():1-12. PubMed ID: 1688198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.